ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
50 hedge funds and large institutions have $4.23M invested in Zynerba Pharmaceuticals, Inc in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
86% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 14
Holders
50
Holding in Top 10
–
Calls
$37K
Puts
$5K
Top Buyers
| 1 | +$10.3K | |
| 2 | +$8.02K | |
| 3 | +$6.69K | |
| 4 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$6.13K |
| 5 |
BWP
Bernardo Wealth Planning
Harleysville,
Pennsylvania
|
+$4.3K |
Top Sellers
| 1 | -$660K | |
| 2 | -$396K | |
| 3 | -$197K | |
| 4 |
Renaissance Technologies
New York
|
-$143K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$96K |